INVIVO THERAPEUTICS HLDGS CORP
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NVIVQ and buy or sell other stocks, ETFs, and their options commission-free!About NVIVQ
InVivo Therapeutics Corporation is a medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injuries. The company was founded in 2005 on the basis of research initiated in Cambridge, Massachusetts, United States.
CEORichard Toselli, MD, MBA
CEORichard Toselli, MD, MBA
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2005
Founded2005
Employees—
Employees—
NVIVQ Key Statistics
Market cap1.15M
Market cap1.15M
Price-Earnings ratio-0.11
Price-Earnings ratio-0.11
Dividend yield—
Dividend yield—
Average volume11.58K
Average volume11.58K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.4348
52 Week high$0.4348
52 Week low$0.15
52 Week low$0.15
Stock Snapshot
The current INVIVO THERAPEUTICS HLDGS CORP(NVIVQ) stock price is $0.37, with a market capitalization of 1.15M. The stock trades at a price-to-earnings (P/E) ratio of -0.11.
During the trading day, INVIVO THERAPEUTICS HLDGS CORP(NVIVQ) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for INVIVO THERAPEUTICS HLDGS CORP(NVIVQ) stock has reached 0, versus its average volume of 11.58K.
The stock's 52-week range extends from a low of $0.15 to a high of $0.43.
The stock's 52-week range extends from a low of $0.15 to a high of $0.43.
People also own
Based on the portfolios of people who own NVIVQ. This list is generated using Robinhood data, and it’s not a recommendation.